These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28638464)

  • 1. Overexpression of PAK1 Correlates with Aberrant Expression of EMT Markers and Poor Prognosis in Non-Small Cell Lung Cancer.
    Yang Z; Wang H; Xia L; Oyang L; Zhou Y; Zhang B; Chen X; Luo X; Liao Q; Liang J
    J Cancer; 2017; 8(8):1484-1491. PubMed ID: 28638464
    [No Abstract]   [Full Text] [Related]  

  • 2. Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer.
    Zhou Y; Liao Q; Han Y; Chen J; Liu Z; Ling H; Zhang J; Yang W; Oyang L; Xia L; Wang L; Wang H; Xue L; Wang H; Hu B
    J Cancer; 2016; 7(14):2100-2109. PubMed ID: 27877226
    [No Abstract]   [Full Text] [Related]  

  • 3. HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma.
    Xia YY; Yin L; Tian H; Guo WJ; Jiang N; Jiang XS; Wu J; Chen M; Wu JZ; He X
    Onco Targets Ther; 2015; 8():169-76. PubMed ID: 25653540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
    Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer.
    Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH
    Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
    Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
    PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
    Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
    Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAK1 as a Potential Therapeutic Target in Male Smokers with EGFR-Mutant Non-Small Cell Lung Cancer.
    Chung JH; Kim T; Kang YJ; Yoon SH; Kim YS; Lee SK; Son JH; Son B; Kim DH
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33261184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver kinase B1 correlates with prognosis and epithelial-mesenchymal transition of resectable early stage non-small cell lung cancer.
    Qin Z; Xie R; Zhang W; Wan M; Zhang L; Wang H; Li N; Qin Q; Yao Y
    Transl Cancer Res; 2020 Feb; 9(2):639-646. PubMed ID: 35117409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
    Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
    Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis.
    Matsubara T; Tagawa T; Takada K; Toyokawa G; Shimokawa M; Kozuma Y; Akamine T; Haro A; Osoegawa A; Mori M
    Clin Lung Cancer; 2019 Jul; 20(4):e504-e513. PubMed ID: 31103348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of Stathmin1 expression and epithelial-mesenchymal transition in curatively resected gastric cancer.
    Ke B; Guo XF; Li N; Wu LL; Li B; Zhang RP; Liang H
    Mol Clin Oncol; 2019 Feb; 10(2):214-222. PubMed ID: 30680197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
    Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
    Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
    Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.
    Aruga N; Kijima H; Masuda R; Onozawa H; Yoshizawa T; Tanaka M; Inokuchi S; Iwazaki M
    Tokai J Exp Clin Med; 2018 Apr; 43(1):5-13. PubMed ID: 29637533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study.
    Wang G; Ma W; Li Y; Jiang Y; Ma G; Zhang X; Meng L; Du J
    Eur J Cardiothorac Surg; 2018 Aug; 54(2):237-245. PubMed ID: 29415155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical significance of autophagic protein LC3B and EMT markers in gastric cancer.
    Wang JY; Wu T; Ma W; Li S; Jing WJ; Ma J; Chen DM; Guo XJ; Nan KJ
    Cancer Manag Res; 2018; 10():1479-1486. PubMed ID: 29928144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.